Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OVAL (Observed Variability and Lability) allows you to quantify glucose homeostasis in type 2 diabetes and control subjects. OVAL is a robust method for measuring glucose:insulin homeostasis in control and type 2 diabetes subjects. It has the capacity to quantify sequential deterioration and monitor effects of intervention.

OVAL is an excel enabled workbook and should work on Microsoft Excel versions 2007, 2010, 2011. It might work on other versions but they have not been tested. The workbook uses macros to calculate the methods of OVAL so in order for it to work you need to enable macros.

OVAL is free to use for academic and non-commercial purposes. If you wish to use it commercially
please contact Nathan Hill. 

Access the OVAL research paper via pubmed

Download OVAL Calc


The zip file is password protected. The password is: nathan2011

 OVAL Calc by Nathan R Hill - © University of Oxford 2010+

General disclaimer

This software is provided by the copyright holders and contributors "as is" and any express or implied warranties, including, but not limited to, the implied warranties of merchantability and fitness for a particular purpose are disclaimed. In no event shall the copyright owner or contributors be liable for any direct, indirect, incidental, special, exemplary, or consequential damages (including, but not limited to, procurement of substitute goods or services; loss of use, data, or profits; or business interruption) however caused and on any theory of liability, whether in contract, strict liability, or tort (including negligence or otherwise) arising in any way out of the use of this software, even if advised of the possibility of such damage. By using this software you agree to these terms. 

In this section

Keep informed

For the latest news and updates, sign up for our newsletter.

Sign up